Parallel Advisors’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-184
Closed -$45K 3591
2022
Q3
$45K Sell
184
-14
-7% -$3.78K ﹤0.01% 1315
2022
Q2
$49K Buy
198
+10
+5% +$2.7K ﹤0.01% 1270
2022
Q1
$62K Buy
188
+39
+26% +$12K ﹤0.01% 1199
2021
Q4
$54K Buy
149
+32
+27% +$10.8K ﹤0.01% 1283
2021
Q3
$38K Buy
117
+19
+19% +$6.44K ﹤0.01% 1413
2021
Q2
$31K Sell
98
-12
-11% -$3.68K ﹤0.01% 1469
2021
Q1
$35K Buy
110
+21
+24% +$6.72K ﹤0.01% 1345
2020
Q4
$29K Sell
89
-16
-15% -$4.43K ﹤0.01% 1344
2020
Q3
$29K Buy
105
+16
+18% +$4.61K ﹤0.01% 1303
2020
Q2
$21K Buy
89
+47
+112% +$9.44K ﹤0.01% 1406
2020
Q1
$6K Buy
42
+19
+83% +$3.15K ﹤0.01% 1866
2019
Q4
$4K Buy
23
+14
+156% +$2.6K ﹤0.01% 2073
2019
Q3
$2K Buy
+9
New +$1.95K ﹤0.01% 2224
2019
Q2
Sell
-35
Closed -$10K 2481
2019
Q1
$10K Buy
35
+10
+40% +$3.32K ﹤0.01% 1548
2018
Q4
$8K Buy
+25
New +$8.68K ﹤0.01% 1437
2018
Q3
Sell
-12
Closed -$4K 2326
2018
Q2
$4K Buy
+12
New +$4.35K ﹤0.01% 1705

Other funds holding ABMD

Parallel Advisors's ABMD Position: Q4 2022 in Review

Parallel Advisors sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 184 shares — an estimated $45K sold.

Parallel Advisors first reported a position in ABMD in Q2 2018 and held it in 16 quarters. The position peaked at $62K in Q1 2022. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Parallel Advisors reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Parallel Advisors sold 184 Abiomed Inc shares in Q4 2022, an estimated $45K.
  • Parallel Advisors first reported a position in Abiomed Inc in Q2 2018 and held it in 16 quarters.
  • Parallel Advisors's Abiomed Inc position peaked at $62K in Q1 2022.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Parallel Advisors's 13F filing for Q4 2022, filed 6 Feb 2023.